Otwarty dostęp

Understanding the Correlation between Blood Profile and the Duration of Hospitalization in Pediatric Bronchopneumonia Patients: A Cross-Sectional Original Article

, ,  oraz   
31 lip 2024

Zacytuj
Pobierz okładkę

Baseline Patient Characteristics

Characteristic DOH ≤ 4 days (n=105) DOH > 4 days (n=179) Total (n= 284)
Age (%)
1 month - 1 year 33 (31.4%) 39 (21.8%) 72 (25.4%)
> 1 year 72 (68.6%) 140 (78.2%) 212 (74.6%)

Sex (%)
Female 42 (40.0%) 86 (48.0%) 128 (45.1%)
Male 63 (60.0%) 93 (52.0%) 156 (54.9%)

IV Antibiotics (%)
Ceftriaxone 44 (41.9%) 82 (45.8%) 126 (44.4%)
Ceftriaxone + Gentamicin 43 (41.0%) 68 (38.0%) 111 (39.1%)
Cefotaxime 7 (6.7%) 9 (5.0%) 16 (5.6%)
Cefotaxime + Gentamicin 7 (6.7%) 13 (7.3%) 20 (7.0%)
Ceftazidime 4 (3.8%) 7 (3.9%) 11 (3.9%)

Statistical Analysis: Significance and Correlation between the Differential White Cell Counts and DOH

Differential Blood Profiles (on the day of admission) Reference Range Parameter Median (Minimum-Maximum) P-value Correlation Coefficient (R)
NLR < 3.13 DOH ≤ 4 days 0.89 (0.11–1.84) <0.0001* 0.6495
> 4 days 3.98 (0.21–73.20) 0.2439
Total 2.43 (0.11–73.20) 0.3206

Neutrophils (%) 50–70 DOH ≤ 4 days 41.7 (4.14–60.8) <0.0001* 0.7363
> 4 days 72 (15–92.2) −0.1828
Total 62.9 (4.14–92.2) 0.4396

Lymphocytes (%) 25–40 DOH ≤ 4 days 46.4 (6.68–81.5) <0.0001* −0.7713
> 4 days 18.5 (2.54–70.2) 0.1095
Total 26.75 (2.54–81.5) −0.4889

Leukocytes (109/L) 5.0–21.0 DOH ≤ 4 days 10.2 (2.1–32.3) 0.00039* −0.0758
> 4 days 12.9 (3.0–54.6) 0.0393
Total 11.95 (2.1–54.6) 0.1523

Thrombocytes (109/L) 150–400 DOH ≤ 4 days 338 (93–849) 0.44481 −0.0714
> 4 days 353 (22.6–732) −0.0688
Total 346 (22.6–849) −0.0299